These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18524605)

  • 1. Duocarmycin-based prodrugs for cancer prodrug monotherapy.
    Tietze LF; Schuster HJ; Schmuck K; Schuberth I; Alves F
    Bioorg Med Chem; 2008 Jun; 16(12):6312-8. PubMed ID: 18524605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy.
    Tietze LF; von Hof JM; Krewer B; Müller M; Major F; Schuster HJ; Schuberth I; Alves F
    ChemMedChem; 2008 Dec; 3(12):1946-55. PubMed ID: 19021160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological studies of different duocarmycin based glycosidic prodrugs for their use in the antibody-directed enzyme prodrug therapy.
    Tietze LF; Schuster HJ; Krewer B; Schuberth I
    J Med Chem; 2009 Jan; 52(2):537-43. PubMed ID: 19143570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of prodrugs based on the natural antibiotic duocarmycin for use in ADEPT and PMT.
    Tietze LF; Schmuck K; Schuster HJ; Müller M; Schuberth I
    Chemistry; 2011 Feb; 17(6):1922-9. PubMed ID: 21274943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosidic prodrugs of highly potent bifunctional duocarmycin derivatives for selective treatment of cancer.
    Tietze LF; von Hof JM; Müller M; Krewer B; Schuberth I
    Angew Chem Int Ed Engl; 2010 Sep; 49(40):7336-9. PubMed ID: 20799305
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective cancer therapy by extracellular activation of a highly potent glycosidic duocarmycin analogue.
    Chen KC; Schmuck K; Tietze LF; Roffler SR
    Mol Pharm; 2013 May; 10(5):1773-82. PubMed ID: 23448264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective treatment of cancer: synthesis, biological evaluation and structural elucidation of novel analogues of the antibiotic CC-1065 and the duocarmycins.
    Tietze LF; Major F; Schuberth I; Spiegl DA; Krewer B; Maksimenka K; Bringmann G; Magull J
    Chemistry; 2007; 13(16):4396-409. PubMed ID: 17455190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoactivatable prodrugs of highly potent duocarmycin analogues for a selective cancer therapy.
    Tietze LF; Müller M; Duefert SC; Schmuck K; Schuberth I
    Chemistry; 2013 Jan; 19(5):1726-31. PubMed ID: 23225610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of the first spacer containing prodrug of a duocarmycin analogue and determination of its biological activity.
    Schuster HJ; Krewer B; von Hof JM; Schmuck K; Schuberth I; Alves F; Tietze LF
    Org Biomol Chem; 2010 Apr; 8(8):1833-42. PubMed ID: 20449487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-directed enzyme prodrug therapy: a promising approach for a selective treatment of cancer based on prodrugs and monoclonal antibodies.
    Tietze LF; Krewer B
    Chem Biol Drug Des; 2009 Sep; 74(3):205-11. PubMed ID: 19660031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
    Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantio- and diastereoselective synthesis of duocarmycine-based prodrugs for a selective treatment of cancer by epoxide opening.
    Tietze LF; Schuster HJ; Hampel SM; Rühl S; Pfoh R
    Chemistry; 2008; 14(3):895-901. PubMed ID: 18033701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy.
    Leu YL; Chen CS; Wu YJ; Chern JW
    J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT).
    Leu YL; Roffler SR; Chern JW
    J Med Chem; 1999 Sep; 42(18):3623-8. PubMed ID: 10479293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of the suberoylanilide hydroxamic acid (SAHA) beta-glucuronide and beta-galactoside for application in selective prodrug chemotherapy.
    Thomas M; Rivault F; Tranoy-Opalinski I; Roche J; Gesson JP; Papot S
    Bioorg Med Chem Lett; 2007 Feb; 17(4):983-6. PubMed ID: 17157009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel analogues of CC-1065 and the duocarmycins for the use in targeted tumour therapies.
    Tietze LF; Krewer B
    Anticancer Agents Med Chem; 2009 Mar; 9(3):304-25. PubMed ID: 19275523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a novel pentagastrin-drug conjugate for a targeted tumor therapy.
    Tietze LF; Panknin O; Major F; Krewer B
    Chemistry; 2008; 14(9):2811-8. PubMed ID: 18214880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy.
    Masterson LA; Spanswick VJ; Hartley JA; Begent RH; Howard PW; Thurston DE
    Bioorg Med Chem Lett; 2006 Jan; 16(2):252-6. PubMed ID: 16290933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA.
    Daniell K; Stewart M; Madsen E; Le M; Handl H; Brooks N; Kiakos K; Hartley JA; Lee M
    Bioorg Med Chem Lett; 2005 Jan; 15(1):177-80. PubMed ID: 15582435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A heterodimeric glucuronide prodrug for cancer tritherapy: the double role of the chemical amplifier.
    Grinda M; Clarhaut J; Tranoy-Opalinski I; Renoux B; Monvoisin A; Cronier L; Papot S
    ChemMedChem; 2011 Dec; 6(12):2137-41. PubMed ID: 21815268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.